Tag : Leukemia

Pediatrics

Partnership with China Prompts Change in Care for High-Risk Type of Leukemia

Newsemia
Researchers from St. Jude Children’s Research Hospital and the Chinese Children’s Cancer Group led the first randomized, Phase III clinical trial comparing targeted therapies for...
Latest News

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

Newsemia
A stem cell transplant – also called a bone marrow transplant – is a common treatment for blood cancers, such as acute myeloid leukemia. Source...
Gastroenterology

World Trade Center rescue and recovery workers found to have increased leukemia incidence

Newsemia
Responders who worked at the World Trade Center site after the attacks on September 11, 2001, have an increased overall cancer incidence compared to the...
Pharma / Biotech

Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician's perspective.

Newsemia
Related Articles Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician’s perspective. Daru. 2020 Jan 03;: Authors: Pushpam D, Bakhshi S Abstract OBJECTIVE:...
Latest News

Artificial intelligence can detect AML with high reliability

Newsemia
Artificial intelligence can detect one of the most common forms of blood cancer – acute myeloid leukemia (AML) – with high reliability. Source link...
Latest News

Immunotherapy more effective than chemotherapy for children, young adults with relapsed B-ALL

Newsemia
New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for children and young adults with...
Pediatrics

ASH: Research revises classification of acute myeloid leukemia and myelodysplastic syndrome

Newsemia
Results from a study conducted by St. Jude Children’s Research Hospital and the Munich Leukemia Laboratory were presented today as a late-breaking abstract at the...
Latest News

Irutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Newsemia
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) today announced results from an extended follow-up analysis of patients in its randomized Phase 3 clinical trial, E1912. Source...
Neurology

New approach can improve the activity of CAR-T cells against blood and solid cancers

Newsemia
A new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiveness against human cancer cells grown in...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy